New drug combo aims to fight tough childhood cancer
NCT ID NCT06540963
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new pill called tipifarnib combined with an FDA-approved drug, naxitamab, for people with neuroblastoma that has come back or not responded to treatment. The goal is to see if the combination is safe and helps shrink tumors or slow the disease. The trial is for patients aged 1 to 21 years at diagnosis, with about 98 participants expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Arkansas Children's Hospital
RECRUITINGLittle Rock, Arkansas, 72202, United States
-
Arnold Palmer Hospital for Children
RECRUITINGOrlando, Florida, 32806, United States
-
Cardinal Glennon Children's Medical Center
RECRUITINGSt Louis, Missouri, 63104, United States
-
Children's Medical Center
RECRUITINGDallas, Texas, 75235, United States
-
Connecticut Children's Hospital
RECRUITINGHartford, Connecticut, 06106, United States
-
Dell Children's Blood and Cancer Center
RECRUITINGAustin, Texas, 78723, United States
-
Duke University
RECRUITINGDurham, North Carolina, 27708, United States
-
Kapiolani Medical Center for Women and Children
RECRUITINGHonolulu, Hawaii, 96813, United States
-
Monroe Carrell Jr. Children's Hospital at Vanderbilt
RECRUITINGNashville, Tennessee, 37232, United States
-
Nicklaus Children's Hospital
RECRUITINGMiami, Florida, 33155, United States
-
Penn State Milton S. Hershey Medical Center and Children's Hospital
RECRUITINGHershey, Pennsylvania, 17033, United States
-
Randall Children's Hospital
RECRUITINGPortland, Oregon, 97227, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can a shorter chemo combo tame High-Risk neuroblastoma?
- Can a radioactive 'Smart Bomb' take down resistant childhood cancers?
- Can AI read tumor slides to outsmart childhood cancer?
- Can a radioated molecule shrink untreatable neuroblastoma?
- Slowing down immunotherapy infusion may reduce pain in children with Tough-to-Treat neuroblastoma